Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.

Although cases with higher levels of c-Raf-1 expression showed increased tumor-free survival compared with cases with lower c-Raf-1 expression levels, this difference did not reach statistical significance.

also in 111,027 other papers